2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of Hims & Hers Health Inc. (HIMS) based on the data provided.

**1. Return Rate vs. S&P 500 (VOO)**

*   **Company Overview:** Hims & Hers Health Inc. is a telehealth company that offers personalized health and wellness solutions to consumers.
*   **HIMS Cumulative Return:** 114.24%
*   **VOO Cumulative Return:** 69.64%
*   **Divergence:** 39.6 (Relative Divergence: 30.1)

**Analysis:** HIMS has significantly outperformed the S&P 500 (VOO) in terms of cumulative return. The divergence of 39.6 indicates a substantial difference in performance. However, the relative divergence of 30.1 suggests that the current performance difference is towards the lower end of its historical range. This may indicate that further outperformance is less likely to continue at the same rate, or a potential correction is possible.

**Alpha, Beta Analysis:**

| Year       | CAGR     | MDD     | Alpha   | Beta | Cap(B) |
|------------|----------|---------|---------|------|--------|
| 2020-2022  | -19.0%   | 67.1%   | -17.0%  | 0.7  | 1.5    |
| 2021-2023  | -65.0%   | 67.1%   | -66.0%  | 1.6  | 2.0    |
| 2022-2024  | 119.0%   | 42.0%   | 99.0%  | 1.7  | 5.5    |
| 2023-2025  | 114.0%   | 57.5%   | 52.0%  | 2.1  | 7.4    |

**Analysis:**

*   **CAGR:** The CAGR (Compound Annual Growth Rate) shows a volatile history, with negative growth in earlier periods and strong positive growth in recent periods.
*   **MDD:** The Maximum Drawdown (MDD) indicates significant risk, particularly in the earlier periods.
*   **Alpha:** A positive Alpha indicates outperformance relative to the market, which is evident in the later periods (2022-2024 and 2023-2025).
*   **Beta:** The Beta values are consistently above 1, indicating that HIMS is more volatile than the market (S&P 500). It also appears that the beta has been trending up recently.
*   **Cap(B):** The market capitalization has grown substantially over the analyzed periods, indicating an increasing footprint in the market.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 33.41
*   **Previous Close:** 32.47
*   **Change:** 2.89
*   **5-day SMA:** 33.466
*   **20-day SMA:** 36.064
*   **60-day SMA:** 41.5878

**Analysis:** The stock price closed higher than the previous close. The 5-day SMA is slightly below the current price, while the 20-day and 60-day SMAs are significantly higher, suggesting a recent downward trend.

**3. RSI, PPO, and Expected Return**

*   **MRI:** 0.8 (Medium Investment)
*   **RSI:** 25.88 (Oversold)
*   **PPO:** -0.33 (Negative)
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (26 shares - Very Safe - MRI:0.90) Monthly invest 1.3% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -3.3 (Short-term decline)
*   **Expected Return:** 47.9%

**Analysis:**

*   **MRI:** A medium investment recommendation suggests a balanced risk-reward profile.
*   **RSI:** The RSI is below 30, indicating that the stock may be oversold and potentially due for a rebound.
*   **PPO:** The negative PPO suggests a downward trend in momentum.
*   **Hybrid Signal:** The signal suggests a strong buy recommendation based on the MRI and allocating 100% of available cash.
*   **Divergence Change:** Indicates a short-term decline in relative performance.
*   **Expected Return:** The high expected return suggests optimism for the stock's future performance over a longer investment horizon.

**4. Recent News & Significant Events**

*   **[2026-01-02] HIMS Stock On A Losing Spree:** This article points to concerns about valuation and a recent decline.
*   **[2026-01-03] $HIMS stock fell 3% this week:** Suggests continued negative momentum.
*   **[2025-12-16] Hims & Hers Health (HIMS): Taking Stock of Valuation After a Sharp 90‑Day Pullback:** More valuation concerns and price corrections.
*   **[2025-11-17] Hims & Hers Health, Inc. Announces $250 Million Share Repurchase Program Authorization:** This is a positive development, as share buybacks can increase shareholder value.
*   **[2026-01-01] HIMS Stock Falls -8.7% With A 7-day Losing Spree On Valuation Concerns:** Reinforces the negative sentiment around valuation.
*   **[2025-12-29] Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar:** Points to potential uncertainties related to expansion and broader economic factors.

**Analysis:** The news sentiment is mixed. While the share repurchase program is positive, the majority of recent headlines point to concerns about valuation, price declines, and uncertainty regarding future growth.

**4-2) Analyst Opinions**

*   **Mean:** Not Available
*   **Opinions:** 12
*   **Target Price (avg/high/low):** 44.67 / 85.00 / 25.00
*   **Recent Rating Changes:** Not Available

**Analysis:** The analyst target price range is wide, indicating differing opinions on the stock's potential. The average target price of $44.67 suggests some upside from the current price.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출     |
|------------|------|----------|
| 2025-11-03 | 0.07 | 0.60 B$  |
| 2025-08-04 | 0.19 | 0.54 B$  |
| 2025-05-05 | 0.22 | 0.59 B$  |
| 2024-11-04 | 0.35 | 0.40 B$  |
| 2025-11-03 | 0.35 | 0.40 B$  |

**Analysis:**

*   **EPS (Earnings Per Share):** EPS has fluctuated over the past quarters, with a slight downward trend.
*   **Revenue:** Revenue has generally increased over the past quarters, indicating growth in the company's sales.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $0.60B    | 73.80%        |
| 2025-06-30   | $0.54B    | 76.39%        |
| 2025-03-31   | $0.59B    | 73.50%        |
| 2024-12-31   | $0.48B    | 76.81%        |
| 2024-09-30   | $0.40B    | 79.16%        |

**Analysis:**

*   **Revenue:** Revenue shows a clear upward trend, confirming consistent growth.
*   **Profit Margin:** Profit margins are consistently high, indicating strong profitability.

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-09-30   | $0.58B    | 2.72%     |
| 2025-06-30   | $0.56B    | 7.55%     |
| 2025-03-31   | $0.55B    | 9.01%     |
| 2024-12-31   | $0.48B    | 5.46%     |
| 2024-09-30   | $0.44B    | 17.18%    |

**Analysis:**

*   **Equity:** Equity is increasing, indicating a strengthening financial position.
*   **ROE (Return on Equity):** ROE has fluctuated and is currently lower compared to past periods, potentially indicating a less efficient use of equity to generate profits.

**7. Comprehensive Analysis**

Hims & Hers Health Inc. (HIMS) exhibits a mixed picture.

*   **Positives:**
    *   Significant outperformance relative to the S&P 500 over a longer time frame.
    *   Strong revenue growth and high profit margins.
    *   The recent buy rating and high expected return suggest good future performance
    *   A share repurchase program can boost shareholder value.
*   **Negatives/Concerns:**
    *   Recent negative news sentiment focuses on valuation concerns and price declines.
    *   The stock's high beta indicates greater volatility.
    *   A downward trend is shown in the recent earnings.
    *   Fluctuating ROE and recent decline compared to the past.

**Summary:**

HIMS shows strong growth potential and high profitability, as reflected in its revenue and profit margin trends. However, recent market concerns regarding the stock's valuation and the short-term downward trend highlight the need for caution. The high beta indicates higher volatility, and the recent mixed analyst opinions suggest further research is needed. While the oversold RSI and positive hybrid signal suggest a potential buying opportunity, investors should carefully consider the risks and potential rewards before making any decisions.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.